Floatz logo

c46/ccr5/p140k lentiviral vector-transduced autologous hspcs

HIV Infectious Disease

Fred Hutchinson Cancer CenterCell therapyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

62 Active assets in the HIV Infectious Disease cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
ZIDOVUDINE
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Efavirenz
The Cleveland Clinic
Phase 4BBB
NEVIRAPINE ANHYDROUS
Germans Trias i Pujol Hospital
Phase 4BBB
RITONAVIR
Giovanni Di Perri
Phase 4BBB

View all 50 →

Same molecule, other indications

c46/ccr5/p140k lentiviral vector-transduced autologous hspcs is also rated in:

Hodgkins lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
non-Hodgkin lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →